Dr. Debra E. Freeman, MD

Dr. Freeman practices at Naples Radiation Oncology, P.a. in Naples, Florida.

Dr. Freeman's NPI, 1346254125, was assigned on July 28, 2006. Dr. Freeman graduated from University Of Florida College Of Medicine in 1987. Dr. Freeman holds Florida license ME0059942.

Dr. Freeman's primary practice is Naples Radiation Oncology, P.a., at 2575 Northbrooke Plaza Dr, Naples, FL 34119. The practice phone is (239) 262-5168.

Dr. Freeman's primary practice is Naples Radiation Oncology, P.a. in Naples, Florida. The medical group on file is AQUA Dermatology. Dmand AI also links Dr. Freeman to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Freeman practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Freeman's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Freeman is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dr. Freeman is licensed in Florida.

Dmand AI lists prostate cancer radiation among the conditions Dr. Freeman treats.

CMS data shows 3,212 Medicare services from Dr. Freeman across 15 procedure codes in 2024, for 138 Medicare patients. Medicare paid $439,814 for them. Every service was in an office.

CMS counts 138 Medicare patients who saw Dr. Freeman in 2024. The largest group is 75 to 84, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Freeman's median patient age at 76, with 39% women.

In 2024, Dr. Freeman wrote 60 Medicare Part D claims for 37 patients. 72% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $165 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Freeman for performance year 2024, reported as part of a group. Dr. Freeman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Freeman as offering telehealth.

Dmand AI links 9 papers to Dr. Freeman in 2015. The most frequent topics are Carcinoma, Squamous Cell, Laryngeal Neoplasms and Tomography, X-Ray Computed. Dr. Freeman has published most often in Int J Radiat Oncol Biol Phys. Dr. Freeman's most frequent co-authors are William M. Mendenhall, MD, Anthony A. Mancuso, MD and James Thomas Parsons, MD.

Dmand AI links Dr. Freeman to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ. RPCR, Inc. sponsors the most, 2.

CMS Open Payments shows 13 general payments to Dr. Freeman from 6 drug and device companies from 2016 to 2024. Honoraria make up the largest share, 54% of the total. Accuray Incorporated paid the most, $1,290.

Dr. Freeman graduated from University Of Florida College Of Medicine in 1987.

Dr. Freeman is in network with 17 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.